Tomasson Receives NCI Seed Grant
April 18, 2018 - Dr. Michael Tomasson has received a one-year, $60,000 seed grant from the Holden Comprehensive Cancer Center (HCCC) to examine determinants responsible for the transition of certain neoplasms into myelomas.